Pharmaceutical compositions

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Anti-idiotypic

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

423409, 260429R, A01N 1100, C01F 1500

Patent

active

043024467

ABSTRACT:
A stable, microcrystalline form of cisplatin, a process for its preparation, and stable, sterile dry-mix formulations thereof which are more rapidly reconstituted with sterile water to produce solutions suitable for intravenous administration to man than are similar formulations containing "regular" cisplatin. The microcrystalline cisplatin and dry-mix formulations thereof are prepared without the use of lyophilization.

REFERENCES:
Greene et al., American Journal of Hospital Pharmacy 36, 38-43, (1979).
Rozencweig et al., Annals of Internal Medicine, 86, 803-812, (1977).
Talley et al., Cancer Chemotherapy Reports, 57, 465-471, (1973).
Rossof et al., Cancer, 30 1451-1456, (1972).
Rosenberg et al., Nature 205 698-699, (1965).
Rosenberg et al., Nature 222 385-386, (1966).
Handelsman et al., Clinical Brochure, Cis Platinum (II), Diamminedichlori de National Cancer Inst., pp. 31 & 32, (1974).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2174708

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.